Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2021/09/02 | N/A | Active, not recruiting |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| COMIRNATY, DISPERSION FOR INJECTION, 30 MICROGRAMS/DOSE (SINGLE-DOSE VIAL) | SIN17016P | INJECTION | 30 mcg/dose | 5/31/2024 | |
| COMIRNATY, DISPERSION FOR INJECTION, 10 MICROGRAMS/DOSE (SINGLE-DOSE VIAL) | SIN17017P | INJECTION | 10 μg/dose | 5/31/2024 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| COMIRNATY OMICRON XBB.1.5 DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED) 30 MICROGRAMS/DOSE | N/A | N/A | N/A | 11/7/2023 |
TGA Drug Approvals
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| COMIRNATY OMICRON XBB.1.5 | 02541831 | Suspension - Intramuscular | 10 MCG / 0.2 ML | N/A | |
| COMIRNATY OMICRON XBB.1.5 | 02541866 | Suspension - Intramuscular | 3 MCG / 0.2 ML | 10/24/2023 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| COMIRNATY OMICRON XBB.1.5 (10 MICROGRAMOS)/DOSIS DISPERSION INYECTABLE | 1201528023 | DISPERSIÓN INYECTABLE | Medicamento Sujeto A Prescripción Médica | Not Commercialized | |
| COMIRNATY OMICRON XBB.1.5 (30 MICROGRAMOS)/DOSIS DISPERSION INYECTABLE | 1201528019 | DISPERSIÓN INYECTABLE | Medicamento Sujeto A Prescripción Médica | Not Commercialized | |
| COMIRNATY OMICRON XBB.1.5 (3 MICROGRAMOS/DOSIS) CONCENTRADO PARA DISPERSION INYECTABLE | 1201528024 | CONCENTRADO PARA DISPERSION INYECTABLE | Medicamento Sujeto A Prescripción Médica | Not Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.